Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCytokinetics, Incorporated Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 4 | -$1.59 | -$1.13 | -$1.35 |
| Q2 2025 | 2 | -$1.37 | -$1.37 | -$1.37 |
| Q3 2025 | 2 | -$1.41 | -$1.41 | -$1.41 |
| Q4 2025 | 2 | -$1.32 | -$1.32 | -$1.32 |
| Q1 2026 | 1 | -$1.10 | -$1.10 | -$1.10 |
| Q2 2026 | 1 | -$1.04 | -$1.04 | -$1.04 |
| Q3 2026 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q4 2026 | 1 | -$0.64 | -$0.64 | -$0.64 |
Cytokinetics, Incorporated Earnings Date And Information
Cytokinetics, Incorporated last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-1.36 earnings per share for the quarter, missing analysts' consensus estimates of $-1.27 by $0.09. The company had revenue of 463,000 for the quarter and had revenue of 7.53 M for the year. Cytokinetics, Incorporated has generated $-5 earnings per share over the last year ($-5.45 diluted earnings per share) and currently has a price-to-earnings ratio of -10.36. Cytokinetics, Incorporated has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
Cytokinetics, Incorporated Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$1.36 | $1.21 M | $463,000 | ||
| 08/09/2024 | Q2 2024 | -$1.31 | $7.61 M | $249,000 | ||
| 05/10/2024 | Q1 2024 | -$1.33 | $835,000 | |||
| 02/28/2024 | Q4 2023 | -$1.38 | $1.67 M | |||
| 11/03/2023 | Q3 2023 | -$1.35 | $20.24 M | $378,000 | ||
| 08/03/2023 | Q2 2023 | -$1.23 | -$1.34 | -0.11 | $5.67 M | $867,000 |
| 05/05/2023 | Q1 2023 | -$1.36 | $4.61 M | |||
| 03/01/2023 | Q4 2022 | -$1.22 | -$1.39 | -0.17 | $1.96 M | |
| 11/04/2022 | Q3 2022 | -$1.88 | $3.51 M | $2.52 M | ||
| 08/05/2022 | Q2 2022 | -$0.34 | $3.73 M | $88.97 M | ||
| 05/06/2022 | Q1 2022 | -$1.19 | $1.15 M | |||
| 02/25/2022 | Q4 2021 | -$0.36 | $55.60 M | |||
| 11/05/2021 | Q3 2021 | -$0.95 | $5.98 M | $5.44 M | ||
| 08/06/2021 | Q2 2021 | -$0.86 | $5.52 M | $2.84 M | ||
| 05/07/2021 | Q1 2021 | -$0.66 | $6.55 M | |||
| 02/26/2021 | Q4 2020 | -$0.62 | $6.72 M | |||
| 11/06/2020 | Q3 2020 | -$0.05 | $4.02 M | $41.69 M | ||
| 08/07/2020 | Q2 2020 | -$0.68 | $4.07 M | $3.59 M | ||
| 05/08/2020 | Q1 2020 | -$0.66 | $3.83 M | |||
| 03/04/2020 | Q4 2019 | -$0.52 | $5.21 M |
Cytokinetics, Incorporated Earnings: FAQ's
When is Cytokinetics, Incorporated's earnings date?
Cytokinetics, Incorporated has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
How can I listen to Cytokinetics, Incorporated's earnings conference
call?
The conference call for Cytokinetics, Incorporated's latest earnings report can be listened to online.
How can I read Cytokinetics, Incorporated's conference call transcript?
The conference call transcript for Cytokinetics, Incorporated's latest earnings report can be read online.
How much revenue does Cytokinetics, Incorporated generate each year?
Cytokinetics, Incorporated (:CYTK) has a recorded annual revenue of $7.53 M.
How much profit does Cytokinetics, Incorporated generate each year?
Cytokinetics, Incorporated (:CYTK) has a recorded net income of $7.53 M. Cytokinetics, Incorporated has generated $-5.45 earnings per share over the last four quarters.
What is Cytokinetics, Incorporated's price-to-earnings ratio?
Cytokinetics, Incorporated (:CYTK) has a price-to-earnings ratio of -10.36 and price/earnings-to-growth ratio is 55.64.